Aptamer Delivery Mechanisms for Pre-Exposure Pollutant Protection

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Conventional approaches fail to protect individuals from exposure to organic pollutants and heavy metals, as they focus on remediation at the source rather than providing personal protection or therapy for elevated exposures, and treatments like chelation therapy are ineffective until harmful levels are absorbed, leading to cumulative and irreversible health effects.

Innovation Solution

Utilizing aptamers, specifically designed nucleic acid strands, to bind and prevent absorption or ingestion of toxic pollutants by introducing them into the body through biocompatible delivery mechanisms such as DNA or RNA strands or engineered probiotic bacterial strains, allowing for targeted binding and elimination of toxins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional chelation therapy is used to treat lead toxicity, then high blood lead levels can be reduced, but treatment is only effective when exposure levels are extremely high and cumulative damage has already occurred

Engineering Contradiction:

Improveeffectiveness of lead toxicity treatmentVSAvoidtime delay in effective treatment

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

The aptamer is introduced into the body before lead exposure occurs, where it circulates and binds to lead ions in real-time, preventing absorption and accumulation. This preliminary protective action eliminates the need to wait for elevated levels to manifest before treatment becomes effective.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The aptamer acts as an intermediary substance that intercepts lead ions in the bloodstream and gastrointestinal tract, forming a stable complex that prevents lead from binding to biological targets. This intermediary mechanism provides continuous protection at low exposure levels before toxicity develops.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Adaptability or versatility

If conventional approaches focus on remediation at the source, then environmental contamination can be addressed, but individual protection from cumulative exposure remains unavailable

Engineering Contradiction:

Improveapplicability to various exposure scenariosVSAvoidindividual accessibility to protection

Core Design Contradiction:

Adaptability or versatilityVSEase of operation

Solution Approach 1:

The aptamer-based system provides self-service protection by circulating within the individual's body and automatically binding to lead ions regardless of exposure source or route. The system requires no external intervention beyond initial aptamer administration and operates autonomously to prevent toxicity.

Inventive Principle:

Principle #25Self-service

Solution Approach 2:

The aptamer provides universal protection against lead exposure through multiple routes (ingestion, inhalation, absorption) and multiple sources (water, food, air), making it applicable to all individual exposure scenarios rather than requiring source-specific interventions.

Inventive Principle:

Principle #6Universality (Multi-functionality)

3Object-affected harmful factors

If lead exposure levels are kept low to prevent cumulative effects, then health outcomes improve, but current monitoring and intervention thresholds are too high to prevent damage

Engineering Contradiction:

Improvehealth impact of lead exposureVSAvoiddetection threshold for lead toxicity

Core Design Contradiction:

Object-affected harmful factorsVSMeasurement precision

Solution Approach 1:

The aptamer serves as a sensitive intermediary that binds to lead ions at trace concentrations in the bloodstream and gastrointestinal tract, enabling detection and intervention at exposure levels far below current monitoring thresholds. This intermediary mechanism allows precise monitoring of lead burden at the molecular level.

Inventive Principle:

Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Aptamers effectively prevent absorption of toxic metals and organic pollutants, reducing the need for chelation therapy and minimizing health risks by expelling them through normal physiological processes, offering both prophylactic and therapeutic benefits.

Implementation Method 1

an aptamer having an affinity for toxic metals such as lead is introduced

Methodology Applied

Scientific EffectAffinity binding:

Implementation Method 2

short nucleic acid strands (DNA or RNA with any chemical base modifications) binds with and prevents absorption or ingestion of toxic organic pollutants

Methodology Applied

Scientific EffectSpecific binding:

Data Source

PatentUS20250313847A1Aptamer-based pollutant protection

Publication Date: 2025.10.09 WORCESTER POLYTECHNIC INSTITUTE

AI summary

An aptamer having an affinity for contaminants or pollutants such as toxic metals and industrial chemicals may be introduced by a biocompatible delivery mechanism such as a DNA or RNA strand to which the aptamer is attached. The delivery mechanism delivers the aptamer, either as a direct nucleic acid sequence or expressed in a cell as a probiotic. When delivered as a prophylactic to the gastrointestinal tract (orally) as an aptamer or expressed within a probiotic cell, this would prevent absorption of metals and would thus reduce or eliminate the need for chelation therapy and thereby reduce disease burden. When used therapeutically, it could be ingested, or injected intravenously. Once bound, the toxic metals are expelled through normal gastrointestinal or urinary processes.